Batch checker
Check a Rivpra Formulation Pvt. Ltd batch number
20 batches by Rivpra Formulation Pvt. Ltd have been declared Not of Standard Quality in CDSCO or state-lab alerts. Type your batch number to check it, or scan the full list below. Full manufacturer record
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sodium Bicarbonate Tablets I.P. 1000 mg | T-2509202Mfg 2025-09 · Exp 2027-08 | The sample does not conform to I.P (Addendum 2024) with respect to the Test of DisintegrationDisintegration | CDTL, IndoreCDSCO lab | Jul 2026 |
| Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup | L-2601029Mfg 2026-01 · Exp 2027-12 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Bromhexine Hydrochloride.Assay | RDTL, ChandigarhCDSCO lab | Jun 2026 |
| Teneligliptin & Metformin Hydrochloride Extended Release tablets IP | T-2503098Mfg 2025-03 · Exp 2027-02 | The sample does not conform to I.P. with respect to the Dissolution and Assay of TeneligliptinAssay | CDL, KolkataCDSCO lab | May 2026 |
| Hydroxychloroquine Sulphate Tablets IP 200mg | T-2511405Mfg 2025-11 · Exp 2027-10 | Dissolution as per IPDissolution | DTL, ThiruvananthapuramState lab | Mar 2026 |
| Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | L-2508006Mfg 2025-08 · Exp 2027-07 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Sodium Bicarbonate Tablets I.P. 1000 mg | T-2504229Mfg 2025-04 · Exp 2027-03 | The sample received does not conform to I.P. 2022 with respect to the test for DisintegrationDisintegration | CDTL, MumbaiCDSCO lab | Feb 2026 |
| Teneligliptin & Metformin Hydrochloride Extended-release Tablets 20mg and 500mg | T-2406105Mfg 2024-06 · Exp 2026-05 | The sample received does not conform to I.P. 2022 with respect to the test of Dissolution (Teneligliptin) and Assay /Content of TeneligliptinAssay | CDTL, MumbaiCDSCO lab | Jan 2026 |
| Teneligliptin & Metformin Hydrochloride Extended-release Tablets 20mg and 500mg | T-2509069Mfg 2025-09 · Exp 2027-08 | The sample received does not conform to I.P. 2022 with respect to the test for Dissolution (Teneligliptin)Dissolution | CDTL, MumbaiCDSCO lab | Jan 2026 |
| Clopidogrel Tablets IP 75 mg | T-2405315Mfg 2024-05 · Exp 2026-04 | The sample received does not conform to IP 2022 specification with respect to the Description only.Description | CDTL, HyderabadCDSCO lab | Jan 2026 |
| Ondansertron Orally Disintegrating Tablets IP 4 mg (ONVIN-4 MD TABLETS ) | RV24012Mfg 2024-05 · Exp 2026-04 | Related SubstancesRelated substances | CDL, KolkataCDSCO lab | May 2025 |
| Sodium Bicarbonate Tablets U.S.P. 1000 mg | T-2401309Mfg 2024-01 · Exp 2025-12 | "Description"Description | CDTL-MumbaiCDSCO lab | Mar 2025 |
| Sodium Bicarbonate Tablets U.S.P. 1000 mg (NABOSIS 1000 mg | T-2307270Mfg 2023-07 · Exp 2025-06 | DescriptionDescription | CDTL HyderabadCDSCO lab | Feb 2025 |
| Ciprofloxacin Tablets U.S.P. 500 mg | T-2401066Mfg 2024-01 · Exp 2025-12 | "Dissolution" of CiprofloxacinDissolution | RDTL GuwahatiCDSCO lab | Nov 2024 |
| Acicarb-650 | T-2407400Mfg 2024-07 · Exp 2026-06 | sample does not conform to IP Specification for enteric coated tablets with respect to Disintegration in Acid stageDisintegration | DTL ChennaiState lab | Nov 2024 |
| Ciprofloxacin Tablets U.S.P. 500 mg | T-2401066Mfg 2024-01 · Exp 2025-12 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Oct 2024 |
| Domperidone Tablets I.P. 10 mg | T-2203140Mfg 2022-03 · Exp 2024-02 | Related SubstancesRelated substances | CDTL KolkataCDSCO lab | Mar 2023 |
| Domperidone Tablets I.P. 10 mg | T-2203139Mfg 2022-03 · Exp 2024-02 | Related SubstancesRelated substances | CDTL KolkataCDSCO lab | Mar 2023 |
| Doxycycline Capsules I.P. 100 mg | C-2106006Mfg 2021-06 · Exp 2023-05 | AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| Calcium Citrate, Vitamin D3, Magnesium Hydroxide and Zinc Tablets (PROCAL TABLETS) | T-2107091Mfg 2021-07 · Exp 2022-12 | Assay of Vitamin D3Assay | RDTL ChandigarhState lab | Feb 2022 |
| Ondansetron Orally Disintegrating Tablets IP 4 mg (ONVIN-4MD TABLETS) | RV21023Mfg 2021-07 · Exp 2023-06 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jan 2022 |
Data: CDSCO NSQ portal, Jan 2019, Jul 2026. Absence from the list is not proof of quality.